Bharat Biotech Current Affairs, GK & News
Covid: WHO recommends 3rd dose for immunocompromised
The World Health Organisation (WHO) has recommended for third dose of immunocompromised, following a four-day meeting of the “Strategic Advisory Group of Experts (SAGE) on Immunization”. The final report on the matter will be issued in December. Key Points According to SAGE, moderately & severely immunocompromised persons should be given an additional dose of all WHO-approved ..
Month: Current Affairs - October, 2021
Category: International Current Affairs • Reports & Indexes Current Affairs
Topics: Bharat Biotech • COVID-19 • Global vaccine strategy by WHO • Malaria vaccine • Strategic Advisory Group of Experts (SAGE) on Immunization • World Health Organisation (WHO)
Nasal Covid Vaccine Gets Regulatory Nod for further trials
India’s first nasal vaccine against COVID-19 has received the nod to conduct phase 2 and 3 clinical trials by the Department of Biotechnology. Key Points Nasal Covid Vaccine has been developed by Bharat Biotech. Vaccine has successfully completed Phase 1 clinical trial in age groups of 18 to 60 years. According to the officials, doses ..
Month: Current Affairs - August, 2021
Category: Science & Technology Current Affairs
Topics: Bharat Biotech • COVID-19 • COVID-19 vaccines • Nasal Covid Vaccine • nasal vaccine BBV154 • Needle Free Covid-19 vaccine
IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP
The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36% of the GDP of the country. Key Findings The GoI recently announced the Liberalised and Accelerated Phase 3 strategy of COVID-19 vaccine. According to the new strategy, ..
Month: Current Affairs - April, 2021
Category: Reports & Indexes Current Affairs
Topics: Bharat Biotech • COVAXIN • COVID-19 vaccine • Covishield • Ind-Ra • Serum Institute of India
COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine
The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered in India. It is manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research. The COVAXIN is produced by making the Corona Virus incapable ..
Month: Current Affairs - April, 2021
Category: India Nation & States Current Affairs
Topics: Bharat Biotech • COVAXIN • COVID-19 vaccine • Covishield • ICMR • Moderna • Pfizer • WHO
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..
Month: Current Affairs - January, 2021
Category: Science & Technology Current Affairs
Topics: Bharat Biotech • COVAXIN • Covishield • DGCI • Emergency Use Authorisation • HGCO19 • ICMR • SPUTNIK V • ZyCov-D